लोड हो रहा है...
Tremelimumab: research and clinical development
The immune checkpoint therapy is a relatively recent strategy that aims to tweak the immune system to effectively attack cancer cells. The understanding of the immune responses and their regulation at the intracellular level and the development of fully humanized monoclonal antibodies are the pillar...
में बचाया:
| में प्रकाशित: | Onco Targets Ther |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Dove Medical Press
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4809326/ https://ncbi.nlm.nih.gov/pubmed/27042127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S65802 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|